Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luminate for Inducing PVD in Non-Proliferative Diabetic Retinopathy
NCT02435862Phase 2Completed
- Sponsor
- Allegro Ophthalmics, LLC
- Start
- Feb 2015
- Primary completion
- Aug 2017
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of risuteganib, sponsored by Allegro Ophthalmics, LLC. Started Feb 2015; status: completed.
02
Drugs
risuteganib
Beyond the preview
Go deeper on NCT02435862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435862.